Original Research
Published on 04 Jan 2024
Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial
in Therapy in Gastroenterology
- 25,053 views
- 5 citations





